Healthcare

Pacific Edge Ltd (ASX:PEB) shares climbed 37.93% to AUD 0.20 during the afternoon session on 15 May 2026 after the cancer diagnostics company announced a favourable Medicare draft coverage proposal involving its Cxbladder tests. The stock has also risen 150% over the past year, …

Atomo Diagnostics (ASX: AT1) remained in focus on 15 May 2026 after confirming the completion of its Share Purchase Plan (SPP), with the company raising AUD44,500 before costs through validShareholderapplications.

Racura Oncology Ltd (ASX:RAC) shares climbed 8.27% to AUD 2.75 during the afternoon session on 15 May 2026 after the company announced a key milestone in its CPACS Phase 1 clinical trial program. The stock has now gained 93.66% over the past year, with …

Bioxyne Limited (ASX:BXN) continues to attract investor attention as its share price extends gains, supported by a combination of recent international supply agreements and ongoing expansion across regulated medicinal cannabis markets. On 14 May 2026, the stock closed at AUD 0.084, up 1.20%, also …

Xenitra (ASX:XEN) updated the market after reporting early commercial traction for its OPAL Real World Asset tokenised sales ecosystem, with the company announcing more than AUD500,000 in product sales during the first month of launch.

Acrux Ltd (ASX:ACR) traded flat at AUD 0.011 during the session on 14 May 2026, although the stock briefly climbed to an intraday high of AUD 0.012 before easing back as selling pressure persisted. While the company released a fresh market update linked to …

Clarity Pharmaceuticals Ltd (ASX:CU6) has returned to investor focus after announcing receipt of a $9.8 millionResearch and Development(R&D) Tax Incentive refund under the Australian Federal Government’s R&D incentive program. The stock traded at AUD 2.86 on 14 May, marginally higher for the session, while …